-
9761por Agrawal, Babita, Singh, Shakti, Gupta, Nancy, Li, Wen, Vedi, Satish, Kumar, Rakesh“…Chronic infection with hepatitis C virus (HCV) afflicts 3% of the world’s population and can lead to serious and late-stage liver diseases. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9762por Canal, Cláudio W., Weber, Matheus N., Cibulski, Samuel P., Silva, Mariana S., Puhl, Daniela E., Stalder, Hanspeter, Peterhans, Ernst“…Hepatitis C virus (HCV) (genus Hepacivirus; family Flaviviridae) is a major human pathogen causing persistent infection and hepatic injury. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9763por Qu, Changbo, Xu, Lei, Yin, Yuebang, Peppelenbosch, Maikel P., Pan, Qiuwei, Wang, Wenshi“…The nucleoside analogue 2’-C-methylcytidine (2CMC), a viral polymerase inhibitor, has been shown to inhibit infection with a variety of viruses, including hepatitis C virus (HCV). Here, we report that 2CMC significantly inhibits the replication of HEV in a subgenomic replication model and in a system using a full-length infectious virus. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9764“…Professor Anna Kramvis, Research Professor of Molecular Virology at the University of the Witwatersrand in Johannesburg, South Africa, talks about direct-acting antiviral treatments against hepatitis C virus (HCV), as well as the perspective of the development of an effective vaccine against HCV. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9765“…Although viral antigens are not recognized by this limited TCR repertoire, MAIT cells are known to be activated in a TCR-independent mechanism during some viral infections, such as hepatitis C virus and influenza virus. In this article, we will review recent works in MAIT cell antigen recognition, activation and the role MAIT cells may play in the process of bacterial and viral infections and pathogenesis of non-infectious diseases.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9766“…Several lines of evidence have highlighted the beneficial effects towards several disease conditions including Type II diabetes, hepatitis C virus, hepatocellular carcinoma, nonalcoholic fatty liver disease and neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9767“…This is especially characteristic of the Flaviviridae family, including hepatitis C virus (HCV) and several flaviviruses. Devoid of an appropriate lipid biosynthetic machinery of their own, these single-strand positive-sense RNA viruses can induce dramatic changes in host metabolic pathways to establish a favorable environment for viral multiplication and acquire essential components to facilitate their assembly and traffic. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9768por Zhong, Hua-Hua, Hu, Shao-Jie, Yu, Bo, Jiang, Sha-Sha, Zhang, Jin, Luo, Dan, Yang, Mei-Wen, Su, Wan-Ying, Shao, Ya-Lan, Deng, Hao-Lin, Hong, Fen-Fang, Yang, Shu-Long“…Aging is associated with high morbidity and a poor prognosis in patients with various liver diseases, including nonalcoholic fatty liver disease, hepatitis C and liver cancer, as well as with surgeries such as partial hepatectomy and liver transplantation. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9769“…Currently, sdAbs are being developed against a number of viruses, including human immunodeficiency virus-1 (HIV-1), influenza viruses, hepatitis C virus (HCV), respiratory syncytial virus (RSV), and enteric viruses. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9770“…With all oral direct‐acting antivirals now widely available for hepatitis C, there are increasing numbers of patients who may be cured but are still at risk of HCC. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9771“…The authors report an extremely rare case of Klebsiella pneumoniae pyomyositis of the left thigh in a patient with type II diabetes mellitus on renal replacement therapy (haemodialysis), with untreated hepatitis C. This patient presented via the dialysis unit with fevers, rigors and a swollen left thigh and knee. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9772“…Recently, genome-scale CRISPR–Cas screens have been used to identify host factors that are required for virus replication, including the replication of clinically relevant viruses such as Zika virus, West Nile virus, dengue virus and hepatitis C virus. In this Review, we discuss the technical aspects of genome-scale knockout screens using CRISPR–Cas technology, and we compare these screens with alternative genetic screening technologies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9773“…Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality worldwide. Chronic hepatitis C virus infection (HCV) is the most common cause of HCC in many European countries, Japan and Pakistan. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9774por Tadokoro, Tomoko, Morishita, Asahiro, Fujita, Koji, Oura, Kyoko, Sakamoto, Teppei, Nomura, Takako, Tani, Joji, Yoneyama, Hirohito, Masaki, Tsutomu“…Combination therapy with ledipasvir and sofosbuvir (LDV/SOF), direct-acting antiviral agents, is highly effective against hepatitis C virus genotype 1 infection. Although LDV/SOF is safer than conventional treatment, reports have indicated that LDV/SOF was discontinued in certain cases due to severe skin disorders. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9775por Yayla, Hatice G., Peng, Feng, Mangion, Ian K., McLaughlin, Mark, Campeau, Louis-Charles, Davies, Ian W., DiRocco, Daniel A., Knowles, Robert R.“…Elbasvir is a potent NS5A antagonist for the treatment of chronic hepatitis C. A seemingly trivial indoline oxidation en route to the target compound was complicated by epimerization of a stereogenic hemiaminal center under most standard oxidation conditions. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9776por Lavingia, Kedar, Torabi, Ramyar, Kim, Samuel W., Hughes, Marybeth S., Feliberti, Eric C., Perry, Roger R.“…BACKGROUND: A 64-year-old male was found to have a right adrenal incidentaloma during work-up for elevated liver transaminase levels, later found to be from hepatitis C. The mass was suspicious for adrenocortical carcinoma on CT imaging. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9777por Mulwa, Lucky S., Jansen, Rolf, Praditya, Dimas F., Mohr, Kathrin I., Wink, Joachim, Steinmann, Eike, Stadler, Marc“…The compounds where tested for biological activities; labindoles A (1) and B (2) exhibited significant activity against Hepatitis C Virus, 9H-carbazole (3), 3-chloro-9H-carbazole (4) and 4-hydroxymethyl-quinoline (5) showed antifungal activities. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9778por Matsuoka, Shunichi, Yamana, Yoichiro, Ishii, Tomotaka, Kumagawa, Mariko, Mizutani, Taku, Kamimura, Shinya, Matsumoto, Naoki, Nakamura, Hitomi, Nirei, Kazushige, Tatsuo, Kanda, Moriyama, Mitsuhiko“…A 70-year-old woman with hepatitis C cirrhosis underwent balloon-occluded retrograde transvenous obliteration for hepatic encephalopathy due to spleno-renal shunt. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9779“…CASE PRESENTATION: 61-year-old male with history of pulmonary fibrosis, cholecystectomy and Hepatitis C underwent transjugular liver biopsy (TJLB) as part of his lung transplant workup. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9780“…A 64-year-old woman with a medical history of morbid obesity, chronic hepatitis C, essential hypertension, multiple episodes of abdominal cellulitis, diabetes mellitus type 2 on insulin, intravenous and subcutaneous drug abuse presented to the emergency department complaining of left lower chest pain for 6 weeks along with multiple episodes of vomiting. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto